---
document_datetime: 2023-09-21 18:48:30
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/bondenza-epar-all-authorised-presentations_en.pdf
document_name: bondenza-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9347748
conversion_datetime: 2025-12-20 14:38:31.01627
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration   | Packaging                  | Content        | Package size          |
|-----------------|-----------------|------------|------------------------|---------------------------|----------------------------|----------------|-----------------------|
| EU/1/03/266/003 | Bondenza        | 150 mg     | Film-coated tablet     | Oral use                  | Blister (PVC/PVDC)         |                | 1 tablet              |
| EU/1/03/266/004 | Bondenza        | 150 mg     | Film-coated tablet     | Oral use                  | Blister (PVC/ PVDC)        |                | 3 tablets             |
| EU/1/03/266/005 | Bondenza        | 3 mg       | Solution for injection | Intravenous               | Pre-filled syringe (glass) | 3 ml (1 mg/ml) | 1 pre-filled syringe  |
| EU/1/03/266/006 | Bondenza        | 3 mg       | Solution for injection | Intravenous               | Pre-filled syringe (glass) | 3 ml (1 mg/ml) | 4 pre-filled syringes |

<!-- image -->